{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T13:33:46Z","timestamp":1791812026244,"version":"4.3.4"},"update-to":[{"DOI":"10.1002\/14651858.cd009019","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2013,12,16]],"date-time":"2013-12-16T00:00:00Z","timestamp":1387152000000}}],"reference-count":84,"publisher":"Wiley","issue":"12","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd009019.pub2","type":"journal-article","created":{"date-parts":[[2013,12,16]],"date-time":"2013-12-16T18:01:52Z","timestamp":1387216912000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":43,"title":["Combination formoterol and budesonide as maintenance and reliever therapy versus combination inhaler maintenance for chronic asthma in adults and children"],"prefix":"10.1002","volume":"2013","author":[{"given":"Kayleigh M","family":"Kew","sequence":"first","affiliation":[{"name":"St George's, University of London; Population Health Sciences and Education; Cranmer Terrace London UK SW17 0RE"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotta","family":"Karner","sequence":"additional","affiliation":[{"name":"BMJ; BMJ-TAG; Tavistock Square London UK WC1H 9JR"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie M","family":"Mindus","sequence":"additional","affiliation":[{"name":"Karolinska University Hospital Solna; Department of Respiratory Medicine and Allergy; Stockholm Sweden SE-171 76"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Ferrara","sequence":"additional","affiliation":[{"name":"Karolinska University Hospital Solna; Department of Respiratory Medicine and Allergy; Stockholm Sweden SE-171 76"},{"name":"Karolinska Institutet; Respiratory Medicine Unit, Department of Medicine; Stockholm Sweden"},{"name":"University of Perugia; Section of Respiratory Diseases, Department of Internal Medicine; Perugia Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2013,12,16]]},"reference":[{"key":"10.1002\/14651858.CD009019.pub2-BIB0002|cit1","first-page":"358s [P2156]","article-title":"Budesonide\/formoterol as maintenance and reliever therapy in uncontrolled asthma compared with high dose salmeterol\/fluticasone: the AHEAD double blind study [Abstract]","volume":"30 Suppl 51","author":"Bousquet","year":"2007","journal-title":"European Respiratory Journal"},{"issue":"12","key":"10.1002\/14651858.CD009019.pub2-BIB0001|cit2","doi-asserted-by":"crossref","first-page":"2437","DOI":"10.1016\/j.rmed.2007.07.014","article-title":"Budesonide\/formoterol for maintenance and relief in uncontrolled asthma vs. high-dose salmeterol\/fluticasone","volume":"101","author":"Bousquet","year":"2007","journal-title":"Respiratory Medicine"},{"key":"10.1002\/14651858.CD009019.pub2-BIB0003|cit3","first-page":"193s [P1185]","article-title":"Budesonide\/formoterol provides better efficacy at a lower or similar cost as compared to high dose salmeterol fluticasone treatment [Abstract]","volume":"30 Suppl 51","author":"Bousquet","year":"2007","journal-title":"European Respiratory Journal"},{"issue":"4","key":"10.1002\/14651858.CD009019.pub2-BIB0004|cit4","first-page":"163","article-title":"Cost-effectiveness analysis of budesonide\/formoterol in the maintenance treatment and as-needed (Symbicort SMART) versus salmeterol\/fluticasone plus terbutaline in the treatment of persistent asthma in Spain","volume":"7","author":"Cisneros","year":"2010","journal-title":"Pharmacoeconomics"},{"issue":"17","key":"10.1002\/14651858.CD009019.pub2-BIB0005|cit5","first-page":"2994","article-title":"Budesonide\/formoterol maintenance and reliever therapy in Chinese patients with asthma","volume":"125","author":"Lin Dr","year":"2012","journal-title":"Chinese Medical Journal"},{"key":"10.1002\/14651858.CD009019.pub2-BIB0006|cit6","unstructured":"NCT00242775 Comparison of the Efficacy\/Safety of Symbicort\u00ae Turbuhaler\u00ae,Seretide\u2122 Diskus\u2122 50\/500 \u00b5g & Terbutaline Turbuhaler\u00ae 0.4 mg www.clinicaltrials.gov"},{"key":"10.1002\/14651858.CD009019.pub2-BIB0007|cit7","first-page":"615s [P3613]","article-title":"Episodic high reliever use with budesonide\/formoterol; maintenance and reliever therapy confers added protection against asthma exacerbations [Abstract]","volume":"30 Suppl 51","author":"Peters","year":"2007","journal-title":"European Respiratory Journal"},{"issue":"3","key":"10.1002\/14651858.CD009019.pub2-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1111\/j.1752-699X.2009.00134.x","article-title":"Cost-effectiveness of budesonide\/formoterol for maintenance and reliever asthma therapy in Denmark - Cost-effectiveness analysis based on five randomised controlled trials","volume":"3","author":"Wickstrom","year":"2009","journal-title":"Clinical Respiratory Journal"},{"key":"10.1002\/14651858.CD009019.pub2-BIB0009|cit9","unstructured":"AstraZeneca SD Comparison of the efficacy and safety of one inhalation of Symbicort\u00ae Turbuhaler\u00ae 160\/4.5 \u00b5g bid plus as-needed with two inhalations of SeretideTM EvohalerTM 25\/125 \u00b5g bid plus Terbutaline Turbuhaler\u00ae 0.4 mg as-needed, and one inhalation of Symbicort\u00ae Turbuhaler\u00ae 320\/9 \u00b5g bid plus Terbutaline Turbuhaler\u00ae 0.4 mg as-needed. A 6-month, randomised, double-blind, double-dummy, parallel-group, active-controlled, multi-centre, phase IIIB study in adult and adolescent asthmatic patients www.astrazenecaclinicaltrials.com\/\u200e"},{"issue":"4","key":"10.1002\/14651858.CD009019.pub2-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"571","DOI":"10.2478\/abm-2010-0072","article-title":"Cost-effectiveness of budesonide\/formoterol maintenance and rescue therapy in Thailand","volume":"4","author":"Boonsawat","year":"2010","journal-title":"Asian Biomedicine"},{"key":"10.1002\/14651858.CD009019.pub2-BIB0011|cit11","first-page":"617s [P3620]","article-title":"Does the choice of ICS\/LABA regimen influence exacerbation rates in asthma patients with high as needed use? [Abstract]","volume":"30 Suppl 51","author":"Buhl","year":"2007","journal-title":"European Respiratory Journal"},{"issue":"9","key":"10.1002\/14651858.CD009019.pub2-BIB0015|cit12","doi-asserted-by":"crossref","first-page":"565","DOI":"10.2165\/11533450-000000000-00000","article-title":"Treatment comparison of budesonide\/formoterol with salmeterol\/fluticasone propionate in adults aged >=16 years with asthma: post hoc analysis of a randomized, double-blind study","volume":"30","author":"Kuna","year":"2010","journal-title":"Clinical Drug Investigation"},{"key":"10.1002\/14651858.CD009019.pub2-BIB0012|cit13","first-page":"357s [P2152]","article-title":"Budesonide\/formoterol for maintenance and relief vs higher dose ICS\/LABA therapy outcomes in patients symptomatic on high dose inhaled corticosteroids (HDICS) [Abstract]","volume":"30 Suppl 51","author":"Kuna","year":"2007","journal-title":"European Respiratory Journal"},{"key":"10.1002\/14651858.CD009019.pub2-BIB0013|cit14","first-page":"205s [P1228]","article-title":"Budesonide\/formoterol as maintenance and reliever therapy reduces asthma exacerbations versus higher maintenance dose of budesonide\/formoterol or salmeterol\/fluticasone [Abstract]","volume":"28 Suppl 50","author":"Kuna","year":"2006","journal-title":"European Respiratory Journal"},{"issue":"5","key":"10.1002\/14651858.CD009019.pub2-BIB0014|cit15","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1111\/j.1742-1241.2007.01338.x","article-title":"Effect of budesonide\/formoterol maintenance and reliever therapy on asthma exacerbations","volume":"61","author":"Kuna","year":"2007","journal-title":"International Journal of Clinical Practice"},{"issue":"2","key":"10.1002\/14651858.CD009019.pub2-BIB0016|cit16","first-page":"e165","article-title":"Budesonide\/formoterol as maintenance and reliever treatment compared to fixed dose combination strategies - a Canadian economic evaluation","volume":"15","author":"Miller","year":"2008","journal-title":"Canadian Journal of Clinical Pharmacology"},{"key":"10.1002\/14651858.CD009019.pub2-BIB0017|cit17","first-page":"214s [P1274]","article-title":"Budesonide\/formoterol (B\/F) as maintenance and relief for asthma improves efficacy and is cost saving versus higher maintenance dose of B\/F or salmeterol\/fluticasone (S\/F) [Abstract]","volume":"28 Suppl 50","author":"Price","year":"2006","journal-title":"European Respiratory Journal"},{"issue":"10","key":"10.1002\/14651858.CD009019.pub2-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1111\/j.1398-9995.2007.01466.x","article-title":"Cost-effectiveness of budesonide\/formoterol for maintenance and reliever asthma therapy","volume":"62","author":"Price","year":"2007","journal-title":"Allergy: European Journal of Allergy and Clinical Immunology"},{"issue":"12","key":"10.1002\/14651858.CD009019.pub2-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"3453","DOI":"10.1185\/03007990802567566","article-title":"Cost-effectiveness analysis of budesonide\/formoterol maintenance and reliever therapy versus fixed combination treatments for asthma in Finland","volume":"24","author":"Tamminen","year":"2008","journal-title":"Current Medical Research and Opinion"},{"issue":"3","key":"10.1002\/14651858.CD009019.pub2-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1111\/j.1752-699X.2009.00134.x","article-title":"Cost-effectiveness of budesonide\/formoterol for maintenance and reliever asthma therapy in Denmark - Cost-effectiveness analysis based on five randomised controlled trials","volume":"3","author":"Wickstrom","year":"2009","journal-title":"Clinical Respiratory Journal"},{"key":"10.1002\/14651858.CD009019.pub2-BIB0021|cit21","unstructured":"NCT00259766 SHARE - Symbicort and Health Economics in a Real Life Evaluation www.clinicaltrials.gov"},{"issue":"10","key":"10.1002\/14651858.CD009019.pub2-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1016\/j.rmed.2008.06.017","article-title":"A real-life cost-effectiveness evaluation of budesonide\/formoterol maintenance and reliever therapy in asthma","volume":"102","author":"Stallberg","year":"2008","journal-title":"Respiratory Medicine"},{"key":"10.1002\/14651858.CD009019.pub2-BIB0023|cit23","unstructured":"Stallberg B Lofdahl CG Skoogh BE Wennergren G Olsson P Neij F Budesonide\/formoterol maintenance and reliever therapy effective treatment at a lower cost [Abstract]. European Respiratory Society Annual Congress; 2008 Oct 4-8; Berlin 2008 [4424]"},{"key":"10.1002\/14651858.CD009019.pub2-BIB0024|cit24","unstructured":"D'Urzo A Vogeimeier C Jaspal M Merino JM Boulet S Symbicort (budesonide\/formoterol) for both maintenance and relief reduces the exacerbation burden compared with titration of seretide (salmeterol\/fluticasone) in patients with asthma, a real life study [Abstract]. American Thoracic Society International Conference; 2005 May 20-25; San Diego 2005 [B35] [Poster: G24]"},{"issue":"7","key":"10.1002\/14651858.CD009019.pub2-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"695","DOI":"10.2165\/00019053-200624070-00008","article-title":"Cost effectiveness of budesonide\/formoterol for maintenance and reliever therapy versus salmeterol\/fluticasone plus salbutamol in the treatment of asthma","volume":"24","author":"Johansson","year":"2006","journal-title":"Pharmacoeconomics"},{"key":"10.1002\/14651858.CD009019.pub2-BIB0026|cit26","first-page":"Abstract No. 43","article-title":"Maintenance plus as needed budesonide\/formoterol is cost effective compared with dose titrated salmeterol\/fluticasone [Abstract]","volume":"26 Suppl 49","author":"Johansson","year":"2005","journal-title":"European Respiratory Journal"},{"issue":"5","key":"10.1002\/14651858.CD009019.pub2-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1155\/2007\/560819","article-title":"Canadian economic evaluation of budesonide-formoterol as maintenance and reliever treatment in patients with moderate to severe asthma","volume":"14","author":"Miller","year":"2007","journal-title":"Canadian Respiratory Journal"},{"key":"10.1002\/14651858.CD009019.pub2-BIB0030|cit28","first-page":"Abstract No. 27","article-title":"Maintenance plus as-needed budesonide\/formoterol vs salmeterol\/fluticasone in a real-life setting [Abstract]","volume":"26 Suppl 49","author":"Vogelmeier","year":"2005","journal-title":"European Respiratory Journal"},{"key":"10.1002\/14651858.CD009019.pub2-BIB0028|cit29","unstructured":"Vogelmeier C D'Urzo A Jaspal M Merino JM Johansson G Boulet S Symbicort for both maintenance and relief reduces exacerbations compared with a titration of Seretide (Advair) in patients with asthma: a real life study [Abstract]. American Thoracic Society International Conference 2005; May 20-25; San Diego 2005 [C33] [Poster: F67]"},{"issue":"5","key":"10.1002\/14651858.CD009019.pub2-BIB0029|cit30","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1183\/09031936.05.00028305","article-title":"Budesonide\/formoterol maintenance and reliever therapy: An effective asthma treatment option?","volume":"26","author":"Vogelmeier","year":"2005","journal-title":"European Respiratory Journal"},{"issue":"7","key":"10.1002\/14651858.CD009019.pub2-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"439","DOI":"10.2165\/11598840-000000000-00000","article-title":"Budesonide\/formoterol maintenance and reliever therapy in Asian patients (aged >=16 years) with asthma: a sub-analysis of the COSMOS study","volume":"32","author":"Vogelmeier","year":"2012","journal-title":"Clinical Drug Investigation"},{"issue":"3","key":"10.1002\/14651858.CD009019.pub2-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1111\/j.1752-699X.2009.00134.x","article-title":"Cost-effectiveness of budesonide\/formoterol for maintenance and reliever asthma therapy in Denmark - Cost-effectiveness analysis based on five randomised controlled trials","volume":"3","author":"Wickstrom","year":"2009","journal-title":"Clinical Respiratory Journal"},{"key":"10.1002\/14651858.CD009019.pub2-BIB0033|cit33","unstructured":"AstraZeneca Symbicort single inhaler therapy for asthma in a general practice setting www.clinicaltrials.gov"},{"key":"10.1002\/14651858.CD009019.pub2-BIB0034|cit34","unstructured":"AstraZeneca SALTO - Symbicort single inhaler therapy use in adolescent adults and adults with persistent asthma www.clinicaltrials.gov"},{"issue":"2","key":"10.1002\/14651858.CD009019.pub2-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1111\/resp.12009","article-title":"Budesonide\/formoterol maintenance and reliever therapy via Turbuhaler versus fixed-dose budesonide\/formoterol plus terbutaline in patients with asthma: phase III study results","volume":"18","author":"Atienza","year":"2013","journal-title":"Respirology"},{"key":"10.1002\/14651858.CD009019.pub2-BIB0036|cit36","first-page":"344s","article-title":"Budesonide\/formoterol single inhaler therapy reduces over reliance on rapid acting reliever medication [Abstract]","volume":"24 Suppl 48","author":"Balanzat","year":"2004","journal-title":"European Respiratory Journal"},{"key":"10.1002\/14651858.CD009019.pub2-BIB0037|cit37","unstructured":"NCT00839800 Study to Investigate the Efficacy of Symbicort SMART. (SAKURA) www.clinicaltrials.gov"},{"key":"10.1002\/14651858.CD009019.pub2-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"32S","DOI":"10.1016\/S0895-4356(98)90098-1","article-title":"Cost effectiveness of preventer-reliever combination in the management of chronic asthma - RCT","volume":"51 Suppl 1","author":"Ghosh","year":"1998","journal-title":"Journal of Clinical Epidemiology"},{"key":"10.1002\/14651858.CD009019.pub2-BIB0039|cit39","unstructured":"Haughney J Aubier M Buhl R Ekstrom T Ostinelli J van Schayck CP Patient characteristics to determine an appropriate maintenance dose of budesonide\/formoterol maintenance and reliever therapy [Abstract]. European Respiratory Society Annual Congress; 2009 Sept 12-16; Vienna 2009 [3051]"},{"key":"10.1002\/14651858.CD009019.pub2-BIB0040|cit40","unstructured":"Haughney J van Schayck OCP Aubier M Ostinelli J Ekstr\u00f6m T J\u00f6rgensen L Budesonide\/formoterol maintenance and reliever therapy use in elderly asthma patients [Abstract]. European Respiratory Society Annual Congress; 2010 Sept 18-22; Barcelona 2010 [P1212]"},{"key":"10.1002\/14651858.CD009019.pub2-BIB0041|cit41","first-page":"Abstract No. 84","article-title":"Single inhaler therapy (SiT) with budesonide\/formoterol (BUD\/FUM) is effective in asthma control [Abstract]","volume":"26 Suppl 49","author":"Loukides","year":"2005","journal-title":"European Respiratory Journal"},{"issue":"5","key":"10.1002\/14651858.CD009019.pub2-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1185\/030079906X100212","article-title":"Maintenance plus reliever budesonide\/formoterol compared with a higher maintenance dose of budesonide\/formoterol plus formoterol as reliever in asthma: An efficacy and cost-effectiveness study","volume":"22","author":"Lundborg","year":"2006","journal-title":"Current Medical Research and Opinion"},{"key":"10.1002\/14651858.CD009019.pub2-BIB0043|cit43","unstructured":"Bateman ED Palmqvist M Juniper EF Zhu Y Ekstrom T Single inhaler therapy with budesonide\/formoterol has superior efficacy to fixed-dose budesonide\/formoterol or a higher dose of budesonide alone [Abstract]. American Thoracic Society 100th International Conference; 2004 May 21-26; Orlando 2004 A37 Poster J75"},{"key":"10.1002\/14651858.CD009019.pub2-BIB0044|cit44","first-page":"Abstract No. 10","article-title":"Budesonide\/formoterol for maintenance and as needed - a new approach to asthma management in children [Abstract]","volume":"26 Suppl 49","author":"Bisgaard","year":"2005","journal-title":"European Respiratory Journal"},{"issue":"6","key":"10.1002\/14651858.CD009019.pub2-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1378\/chest.130.6.1733","article-title":"Budesonide\/formoterol maintenance plus reliever therapy: a new strategy in pediatric asthma","volume":"130","author":"Bisgaard","year":"2006","journal-title":"Chest"},{"issue":"3","key":"10.1002\/14651858.CD009019.pub2-BIB0046|cit46","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1136\/ebn.8.3.78","article-title":"Maintenance and symptom relief with budesonide plus formoterol reduced severe asthma exacerbations","volume":"8","author":"Bruce","year":"2005","journal-title":"Evidence-Based Nursing"},{"issue":"6","key":"10.1002\/14651858.CD009019.pub2-BIB0049|cit47","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1016\/j.jaci.2007.03.007","article-title":"Acute asthma intervention: Insights from the STAY study","volume":"119","author":"O'Byrne","year":"2007","journal-title":"Journal of Allergy & Clinical Immunology"},{"issue":"2","key":"10.1002\/14651858.CD009019.pub2-BIB0047|cit48","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1164\/rccm.200407-884OC","article-title":"Budesonide\/formoterol combination therapy as both maintenance and reliever medication in asthma.[see comment]","volume":"171","author":"O'Byrne","year":"2005","journal-title":"American Journal of Respiratory & Critical Care Medicine"},{"key":"10.1002\/14651858.CD009019.pub2-BIB0048|cit49","unstructured":"O'Byrne PM Godard P Pistolesi M Ekstrom T Single inhaler therapy with budesonide\/formoterol improves asthma control compared with fixed dosing with budesonide\/formoterol or a higher dose of budesonide alone [Abstract]. American Thoracic Society 100th International Conference; 2004 May 21-26; Orlando 2004 A37 Poster J93"},{"key":"10.1002\/14651858.CD009019.pub2-BIB0050|cit50","first-page":"509s","article-title":"Budesonide\/formoterol single inhaler therapy (SiT) provides superior asthma control compared with fixed dose (FD) budesonide or budesonide\/formoterol in patients with severe persistent asthma [Abstract]","volume":"24 Suppl 48","author":"Pistolesi","year":"2004","journal-title":"European Respiratory Journal"},{"issue":"3","key":"10.1002\/14651858.CD009019.pub2-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1111\/j.1752-699X.2009.00134.x","article-title":"Cost-effectiveness of budesonide\/formoterol for maintenance and reliever asthma therapy in Denmark - Cost-effectiveness analysis based on five randomised controlled trials","volume":"3","author":"Wickstrom","year":"2009","journal-title":"Clinical Respiratory Journal"},{"key":"10.1002\/14651858.CD009019.pub2-BIB0052|cit52","unstructured":"AstraZeneca SD Efficacy of Symbicort\u00ae Turbuhaler\u00ae 160\/4.5 \u00ecg as needed versus Oxis\u00ae 4.5 \u00ecg as needed and Bricanyl\u00ae 0.4 mg as needed in adults and adolescents with asthma receiving Symbicort\u00ae Turbuhaler\u00ae 160\/4.5 \u00ecg twice daily as maintenance treatment. A 12-month, randomised, double-blind, parallel-group, active-controlled, phase IIIB, multi-centre study www.astrazenecaclinicaltrials.com\/\u200e"},{"key":"10.1002\/14651858.CD009019.pub2-BIB0053|cit53","first-page":"509s","article-title":"Budesonide\/formoterol single inhaler therapy (SiT) provides superior asthma control compared with fixed dose (FD) budesonide or budesonide\/formoterol in patients with severe persistent asthma [Abstract]","volume":"24 Suppl 48","author":"Pistolesi","year":"2004","journal-title":"European Respiratory Journal"},{"issue":"9537","key":"10.1002\/14651858.CD009019.pub2-BIB0054|cit54","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/S0140-6736(06)69284-2","article-title":"Effect of budesonide in combination with formoterol for reliever therapy in asthma exacerbations: a randomised controlled, double-blind study.[see comment]","volume":"368","author":"Rabe","year":"2006","journal-title":"Lancet"},{"issue":"3","key":"10.1002\/14651858.CD009019.pub2-BIB0055|cit55","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1111\/j.1752-699X.2009.00134.x","article-title":"Cost-effectiveness of budesonide\/formoterol for maintenance and reliever asthma therapy in Denmark - Cost-effectiveness analysis based on five randomised controlled trials","volume":"3","author":"Wickstrom","year":"2009","journal-title":"Clinical Respiratory Journal"},{"key":"10.1002\/14651858.CD009019.pub2-BIB0056|cit56","unstructured":"Riemersma RA Postma DS van der Molen T Budesonide\/formoterol maintenance and reliever therapy for asthma in general practice [Abstract]. American Thoracic Society International Conference; 2008 May 16-21; Toronto 2008 A612[#A29]"},{"issue":"4","key":"10.1002\/14651858.CD009019.pub2-BIB0057|cit57","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003135.pub4","article-title":"Fluticasone versus placebo for chronic asthma in adults and children","author":"Adams","year":"2008","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"4","key":"10.1002\/14651858.CD009019.pub2-BIB0058|cit58","first-page":"161","article-title":"Is the SMART approach better than other treatment approaches for prevention of asthma exacerbations? A meta-analysis","volume":"71","author":"Agarwal","year":"2009","journal-title":"Monaldi Archives for Chest Disease"},{"issue":"7618","key":"10.1002\/14651858.CD009019.pub2-BIB0059|cit59","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1136\/bmj.39273.537778.AD","article-title":"Using a combination inhaler (budesonide plus formoterol) as rescue therapy improves asthma control","volume":"335","author":"Barnes","year":"2007","journal-title":"British Medical Journal"},{"key":"10.1002\/14651858.CD009019.pub2-BIB0060|cit60","doi-asserted-by":"crossref","unstructured":"Bateman ED Harrison TW Quirce S Reddel HK Buhl R Humbert M Overall asthma control achieved with budesonide\/formoterol maintenance and reliever therapy for patients on different treatment steps http:\/\/respiratory-research.com\/content\/12\/1\/38 10.1186\/1465-9921-12-38","DOI":"10.1186\/1465-9921-12-38"},{"issue":"5","key":"10.1002\/14651858.CD009019.pub2-BIB0061|cit61","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1002\/ppul.10381","article-title":"Effect of long-acting Beta2 agonists on exacerbation rates of asthma in children","volume":"36","author":"Bisgaard","year":"2003","journal-title":"Pediatric Pulmonology"},{"key":"10.1002\/14651858.CD009019.pub2-BIB0062|cit62","unstructured":"British Thoracic Society\/ Scottish Intercolleate Guideline Network British Guidelines on the Management of Asthma [revised January 2012] http:\/\/www.sign.ac.uk\/"},{"issue":"4","key":"10.1002\/14651858.CD009019.pub2-BIB0063|cit63","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD006923.pub2","article-title":"Regular treatment with formoterol for chronic asthma: serious adverse events","author":"Cates","year":"2008","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"3","key":"10.1002\/14651858.CD009019.pub2-BIB0064|cit64","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD006363.pub2","article-title":"Regular treatment with salmeterol for chronic asthma: serious adverse events","author":"Cates","year":"2008","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"1","key":"10.1002\/14651858.CD009019.pub2-BIB0065|cit65","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007085.pub2","article-title":"Combination formoterol and inhaled steroid versus beta2-agonist as relief medication for chronic asthma in adults and children","author":"Cates","year":"2009","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"2","key":"10.1002\/14651858.CD009019.pub2-BIB0066|cit66","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007313.pub2","article-title":"Combination formoterol and budesonide as maintenance and reliever therapy versus inhaled steroid maintenance for chronic asthma in adults and children","author":"Cates","year":"2009","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"4","key":"10.1002\/14651858.CD009019.pub2-BIB0067|cit67","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007313.pub3","article-title":"Combination formoterol and budesonide as maintenance and reliever therapy versus current best practice (including inhaled steroid maintenance), for chronic asthma in adults and children","author":"Cates Christopher","year":"2013","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"7","key":"10.1002\/14651858.CD009019.pub2-BIB0068|cit68","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1111\/j.1365-2222.2011.03928.x","article-title":"The clinical impact of single inhaler therapy in asthma","volume":"42","author":"Czarnecka","year":"2012","journal-title":"Clinical and Experimental Allergy"},{"issue":"3","key":"10.1002\/14651858.CD009019.pub2-BIB0069|cit69","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/j.clinthera.2008.03.011","article-title":"Effects of fluticasone propionate\/salmeterol combination on asthma-related health care resource utilization and costs and adherence in children and adults with asthma","volume":"30","author":"Delea","year":"2008","journal-title":"Clinical Therapeutics"},{"issue":"5","key":"10.1002\/14651858.CD009019.pub2-BIB0070|cit70","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1111\/j.1742-1241.2009.02320.x","article-title":"Budesonide\/formoterol for maintenance and reliever therapy of asthma: a meta analysis of randomised controlled trials","volume":"64","author":"Edwards","year":"2010","journal-title":"International Journal of Clinical Practice"},{"issue":"7","key":"10.1002\/14651858.CD009019.pub2-BIB0071|cit71","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1136\/thx.2003.014936","article-title":"Doubling the dose of budesonide versus maintenance treatment in asthma exacerbations","volume":"59","author":"FitzGerald","year":"2004","journal-title":"Thorax"},{"key":"10.1002\/14651858.CD009019.pub2-BIB0072|cit72","unstructured":"GINA Global strategy for asthma management and prevention http:\/\/www.ginasthma.org\/"},{"issue":"4","key":"10.1002\/14651858.CD009019.pub2-BIB0073|cit73","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD005533","article-title":"Combination of inhaled long-acting beta2-agonists and inhaled steroids versus higher dose of inhaled steroids in children and adults with persistent asthma","author":"Greenstone","year":"2005","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"9405","key":"10.1002\/14651858.CD009019.pub2-BIB0074|cit74","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S0140-6736(03)15384-6","article-title":"Doubling the dose of inhaled corticosteroid to prevent asthma exacerbations: randomised controlled trial","volume":"363","author":"Harrison","year":"2004","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD009019.pub2-BIB0075|cit75","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"British Medical Journal"},{"key":"10.1002\/14651858.CD009019.pub2-BIB0076|cit76","volume-title":"Cochrane Handbook for Systematic Reviews of Interventions\u00a0Version 5.0.2 [updated September 2009]. The Cochrane Collaboration","author":"Higgins","year":"2011"},{"issue":"12","key":"10.1002\/14651858.CD009019.pub2-BIB0077|cit77","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD004106.pub4","article-title":"Combination fluticasone and salmeterol versus fixed dose combination budesonide and formoterol for chronic asthma in adults and children","author":"Lasserson","year":"2011","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD009019.pub2-BIB0078|cit78","unstructured":"Lipworth BJ Jackson C A SMART choice for primary care asthma therapy? http:\/\/www.bmj.com\/cgi\/eletters\/335\/7618\/513#178078"},{"issue":"4","key":"10.1002\/14651858.CD009019.pub2-BIB0079|cit79","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD005535","article-title":"Long-acting beta2-agonists versus placebo in addition to inhaled corticosteroids in children and adults with chronic asthma","author":"Ni Chroinin","year":"2005","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"1","key":"10.1002\/14651858.CD009019.pub2-BIB0080|cit80","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1006\/pupt.2000.0260","article-title":"Onset of bronchodilation of budesonide\/formoterol vs. salmeterol\/fluticasone in single inhalers","volume":"14","author":"Palmqvist","year":"2001","journal-title":"Pulmonary Pharmacology and Therapeutics"},{"key":"10.1002\/14651858.CD009019.pub2-BIB0081|cit81","unstructured":"The Nordic Cochrane Centre; Cochrane Collaboration Review Manager (RevMan) Version 5 2008"},{"key":"10.1002\/14651858.CD009019.pub2-BIB0082|cit82","unstructured":"Song F Parekh S Hooper L Loke Y Ryder J Sutton A Dissemination and publication of research findings: an updated review of related biases http:\/\/www.google.co.uk\/url?sa=t&rct=j&q=&esrc=s&source=web&cd=1&ved=0CDYQFjAA&url=http%3A%2F%2Fwww.hta.ac.uk%2Ffullmono%2Fmon1408.pdf&ei=f9TfUdf-C6_T7AbRjICoDg&usg=AFQjCNHXDsDiIJivPVumE_aFvjnvjMhqUw&sig2=bouiXecktYUZw-SPeLE22w&bvm=bv.48705608,d.ZGU&cad=rja 10.3310\/hta14080"},{"issue":"546","key":"10.1002\/14651858.CD009019.pub2-BIB0083|cit83","doi-asserted-by":"crossref","first-page":"37","DOI":"10.3399\/bjgp08X263802","article-title":"Poor adherence with inhaled corticosteroids for asthma: can using a single inhaler containing budesonide and formoterol help?","volume":"58","author":"Sovani","year":"2008","journal-title":"British Journal of General Practice"},{"issue":"1","key":"10.1002\/14651858.CD009019.pub2-BIB0084|cit84","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001385.pub2","article-title":"Long-acting beta2-agonists for chronic asthma in adults and children where background therapy contains varied or no inhaled corticosteroid","author":"Walters","year":"2007","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1002\/14651858.CD009019.pub2\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,25]],"date-time":"2024-09-25T14:51:37Z","timestamp":1727275897000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD009019.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Airways Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2013,12,16]]},"references-count":84,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2013,12]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd009019.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,12,16]]}}}